ARIA guideline 2019: treatment of allergic rhinitis in the German health systemLudger Klimek, Claus Bachert, Oliver Pfaar et al.|Allergologie select|2019Cited by 124
Efficacy and safety of canakinumab in Schnitzler syndrome: A multicenter randomized placebo-controlled studyKaroline Krause, Marcus Maurer, Athanasios Tsianakas et al.|Journal of Allergy and Clinical Immunology|2016Cited by 104
ARIA guideline 2019: treatment of allergic rhinitis in the German health systemLudger Klimek, Sanna Toppila‐Salmi, Claus Bachert et al.|Allergo Journal International|2019Cited by 66
Long-term efficacy of canakinumab in the treatment of Schnitzler syndromeKaroline Krause, Marcus Maurer, Athanasios Tsianakas et al.|Journal of Allergy and Clinical Immunology|2020Cited by 44
Effectiveness of canakinumab treatment in Schnitzler's syndrome: a multi-center randomized placebo-controlled studyKaroline Krause, Marcus Maurer, Athanasios Tsianakas et al.|Pediatric Rheumatology|2015Cited by 6